Wordt geladen...
Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide
Inhibition of protein deacetylation enzymes, alone or in combination with standard chemotherapies, is an exciting addition to cancer therapy. We have investigated the effect of deacetylase inhibition on the metabolism of glioblastoma cells. (1)H NMR metabolomics analysis was used to determine the ma...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4192694/ https://ncbi.nlm.nih.gov/pubmed/25222834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo4030807 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|